
AACR 2026 年会
2026 年 4 月 17–22 日 · San Diego · 共 2429 条
#INSIGHTSBYESMO
0 人 · 0 条
现场
ESMO - Eur. Oncology@myESMO Philippe Aftimos, MD @aftimosp 引用@🔹Small improvement in mPFS with pembrolizumab (vs placebo) + chemotherapy in the KN-B49 ph3 study for endocrine resistant, PDL1+ (CPS≥1) HR+/HER2- MBC 🔹Bigger difference in CPS≥10: small numbers and a secondary endpoint 🔹No OS difference #ESMO2 #ESMOAmbassadors @myESMO